The revision to the Medical Device Directives is being implemented across the EU. This seminar will examine the changes and their impact on the Medical Device industry including: Reclassification, Clinical Data, Performance of Notified Bodies, Vigilance, PMS and Risk Management. In addition the Revision of ‘New Approach’ Legislation will be discussed. This will be an excellent opportunity to understand the implications of the regulatory changes and how they will affect working practices. There will also be an introduction to the Commission’s consultation relating to the recasting of the medical device directives.
Revision to the Medical Device Directives
Feb 1st, 2010Feb 2nd, 2010
Latest in Home










![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)




